Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure - PubMed (original) (raw)
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure
J Bruix et al. Gastroenterology. 1996 Oct.
Abstract
Background & aims: Although resection of hepatocellular carcinoma complicating cirrhosis is restricted to patients with preserved liver function, postoperative hepatic decompensation develops in some patients. The aim of this study was to determine the value of increased portal pressure in the development of postoperative hepatic decompensation.
Methods: Twenty-nine cirrhotic patients with Child-Pugh's class A disease and hepatocellular carcinoma (all except one < 5 cm) scheduled to undergo resection were evaluated by conventional criteria and by a systemic and hepatic hemodynamic study. Predictors of decompensation were assessed among a series of 44 clinical, analytical, tumoral, and hemodynamic parameters.
Results: Eleven patients had unresolved decompensation 3 months after surgery. Bilirubin and blood ureic nitrogen levels, platelet count, wedged hepatic venous pressure, hepatic venous pressure gradient, and indocyanine green intrinsic clearance were significantly associated with unresolved decompensation, but only hepatic venous pressure gradient was significant, in the multivariate analysis (P = 0.0001; odds ratio, 1.90; 95% confidence interval, 1.12-3.22). The preoperative gradient of patients with unresolved decompensation was higher than that of patients without it (13.9 +/- 2.4 and 7.4 +/- 3.5 mm Hg, respectively; P < 0.001).
Conclusions: Cirrhotics with increased portal pressure are at high risk of hepatic decompensation after resection of hepatocellular carcinoma. Surgical resection should therefore be restricted to patients without portal hypertension.
Similar articles
- Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma.
Rajakannu M, Cherqui D, Ciacio O, Golse N, Pittau G, Allard MA, Antonini TM, Coilly A, Sa Cunha A, Castaing D, Samuel D, Guettier C, Adam R, Vibert E. Rajakannu M, et al. Surgery. 2017 Oct;162(4):766-774. doi: 10.1016/j.surg.2017.06.006. Epub 2017 Jul 12. Surgery. 2017. PMID: 28711320 - Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma.
Kanematsu T, Furui J, Yanaga K, Okudaira S, Kamohara Y, Eguchi S. Kanematsu T, et al. Hepatogastroenterology. 2005 Nov-Dec;52(66):1828-31. Hepatogastroenterology. 2005. PMID: 16334786 - Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
Giannini EG, Savarino V, Farinati F, Ciccarese F, Rapaccini G, Marco MD, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. Giannini EG, et al. Liver Int. 2013 Nov;33(10):1594-600. doi: 10.1111/liv.12199. Epub 2013 May 8. Liver Int. 2013. PMID: 23654354 - Liver surgery in cirrhosis and portal hypertension.
Hackl C, Schlitt HJ, Renner P, Lang SA. Hackl C, et al. World J Gastroenterol. 2016 Mar 7;22(9):2725-35. doi: 10.3748/wjg.v22.i9.2725. World J Gastroenterol. 2016. PMID: 26973411 Free PMC article. Review. - Hepatic venous pressure gradient and outcomes in cirrhosis.
Ripoll C. Ripoll C. J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S330-5. doi: 10.1097/MCG.0b013e318150d0f4. J Clin Gastroenterol. 2007. PMID: 17975485 Review.
Cited by
- Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B.
Hou H, Liang L, Deng L, Ye W, Wen Y, Liu J. Hou H, et al. Int J Gen Med. 2024 Jun 25;17:2877-2886. doi: 10.2147/IJGM.S464083. eCollection 2024. Int J Gen Med. 2024. PMID: 38947567 Free PMC article. - PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration.
Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D. Gong Y, et al. J Hepatocell Carcinoma. 2024 May 8;11:813-838. doi: 10.2147/JHC.S450479. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38737383 Free PMC article. - A history of the treatment of primary liver cancer.
Bruix J. Bruix J. Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0147. doi: 10.1097/CLD.0000000000000147. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38707239 Free PMC article. Review. No abstract available. - British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.
Suddle A, Reeves H, Hubner R, Marshall A, Rowe I, Tiniakos D, Hubscher S, Callaway M, Sharma D, See TC, Hawkins M, Ford-Dunn S, Selemani S, Meyer T. Suddle A, et al. Gut. 2024 Jul 11;73(8):1235-1268. doi: 10.1136/gutjnl-2023-331695. Gut. 2024. PMID: 38627031 Free PMC article. - TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?
Bosch J. Bosch J. J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101356. doi: 10.1016/j.jceh.2024.101356. Epub 2024 Feb 1. J Clin Exp Hepatol. 2024. PMID: 38389700 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical